文献速递甲状腺与浅表US

高强度聚焦超声(HIFU)消融联合经皮乙醇注射(PEI)治疗良性甲状腺结节

Combining high-intensity focused ultrasound (HIFU) ablation with percutaneous ethanol injection (PEI) in the treatment of benign thyroid nodules.
PubMed 文献 · Eur Radiol · 2020-09-24

本研究比较HIFU联合PEI与单用HIFU治疗良性甲状腺结节的6个月疗效,联合组147例、单用组181例。联合组3个月和6个月体积缩小率均显著更高,治疗中及治疗后2小时疼痛评分更低,且不增加声带麻痹、皮肤灼伤和恶心呕吐风险。

要点

  • 联合组6个月体积缩小率71.08±21.25%,显著高于单用组61.37±22.76%(p=0.001)。
  • 联合组治疗中疼痛评分2.24±3.07,显著低于单用组4.97±3.21(p<0.001)。
  • 两组声带麻痹、皮肤灼伤、恶心呕吐发生率无显著差异(p>0.05)。

关键影像表现/征象

  • 联合组注射乙醇平均量为1.3±0.7 ml。
  • 联合组「在束」治疗时间26.55 min,显著短于单用组30.26 min(p=0.001)。
  • 联合组治疗后2小时疼痛评分2.23±2.50,显著低于单用组2.97±4.39(p=0.044)。

诊断标准与关键数值

  • 联合组3个月体积缩小率60.41±20.49%,显著大于单用组50.13±21.06%(p=0.001)。
  • 联合组6个月体积缩小率71.08±21.25%,显著大于单用组61.37±22.76%(p=0.001)。
  • 疼痛评分采用0-10视觉模拟量表评估。

临床应用与阅片要点

  • 联合HIFU与PEI可作为良性甲状腺结节的治疗选择,6个月体积缩小率更高且疼痛更轻。
  • 联合方案不增加声带麻痹、皮肤灼伤和恶心呕吐风险,安全性特征与单用HIFU相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Assessing the 6-month efficacy of combined high-intensity focused ultrasound (HIFU) ablation with percutaneous ethanol injection (PEI) in benign thyroid nodules by comparing it with HIFU ablation alone.

METHODS: One hundred and eighty-one (55.2%) patients underwent HIFU alone (group I) while 147 (44.8%) underwent concomitant HIFU and PEI treatment for solid or predominantly solid nodules (group II). Intravenous sedation and analgesia were given before the start of treatment. Extent of nodule shrinkage (by volume reduction ratio (VRR)), pain scores (by 0-10 visual analogue scale) during and after ablation, and rate of vocal cord palsy (VCP), skin burn, and nausea/vomiting were compared between the two groups.

RESULTS: The mean amount of ethanol injected in group II was 1.3 ± 0.7 ml. The 3- and 6-month VRR were significantly greater in group II (60.41 ± 20.49% vs. 50.13 ± 21.06%, p = 0.001; and 71.08 ± 21.25% vs. 61.37 ± 22.76%, p = 0.001, respectively), and "on-beam" treatment time was significantly shorter in group II (26.55 min vs. 30.26 min, p = 0.001). Group II patients reported significantly lower pain score during treatment (2.24 ± 3.07 vs. 4.97 ± 3.21, p < 0.001) and 2 h after treatment (2.23 ± 2.50 vs. 2.97 ± 4.39, p = 0.044). Rates of VCP, skin burn, and nausea or vomiting were not significantly different (p > 0.05).

CONCLUSIONS: The combined HIFU and PEI approach with improved administration of intravenous sedation and analgesia was associated with a significantly better 6-month efficacy than HIFU alone in benign thyroid nodules without compromising the safety and comfort of patients.

KEY POINTS: • Concomitant HIFU and PEI have a better treatment efficacy than HIFU alone. • Concomitant HIFU and PEI have a comparable safety profile as HIFU alone.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lang BHH, Woo YC, Chiu KW, et al. Combining high-intensity focused ultrasound (HIFU) ablation with percutaneous ethanol injection (PEI) in the treatment of benign thyroid nodules. Eur Radiol. 2020. PMID: 32974689. doi:10.1007/s00330-020-07317-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。